Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Q3-FY 26 Unaudited Financial Results
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, 10th February 2026, to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and nine months ended 31st December 2025 (Q3 FY26). The intimation is being made as required under SEBI Listing Regulations. The company's trading window for insiders and their immediate relatives will remain closed until 48 hours after the results are declared, i.e. up to 12th February 2026. The notice is signed by Company Secretary Vipul Kumar Srivastava. No actual financial numbers or business updates have been disclosed in this filing.
This is a routine pre-results intimation and contains no new financial information. Investors should wait for the actual Q3 FY26 results on 10th February 2026 to assess the company's revenue, profitability, and any management commentary that could move the stock.